Safety and Feasibility of Outpatient Surgery in Benign Prostatic Hyperplasia: a Systematic Review and Meta-Analysis
- PMID: 33081521
- DOI: 10.1089/end.2020.0538
Safety and Feasibility of Outpatient Surgery in Benign Prostatic Hyperplasia: a Systematic Review and Meta-Analysis
Abstract
Purpose: Most of the endourologic procedures along the urinary tract have been widely practiced as outpatient operations, including surgery for benign prostatic hyperplasia (BPH). This systematic review and meta-analysis was conducted to assess safety and feasibility of outpatient surgery for patients suffering from symptomatic BPH candidate for endoscopic disobstruction. Materials and Methods: PubMed, Web of Science, Cochrane, and Embase were searched up until March 30, 2020. Methodological index for nonrandomized studies (MINORS) tool was utilized to assess the quality of included studies, and a pooled measure of failure rate (FR) or event rate (ER) estimate was calculated. Further sensitivity analysis, subgroup analysis, and meta-regression were conducted to investigate contribution of moderators to heterogeneity. Results: Twenty studies with a total of 1626 patients treated according to outpatient criteria for endoscopic BPH surgery were included. In total, 18 studies reporting data on immediate hospital readmission and/or inability to discharge after endoscopic procedure presented FR estimates ranging from 1.7% to 51.1%. Pooled FR estimate was 7.8% (95% confidence interval [CI]: 5.2-10.3); Heterogeneity: Q = 76.85; degree of freedom = 17, p < 0.001; I2 = 75.12%. Subgroup analysis according to surgical technique revealed difference among the three approaches with pooled FR of 3% (95% CI: 1-4.9), 7.1% (95% CI: 3.9-10.4), and 11.8% (95% CI: 7-16.7) for transurethral resection of the prostate, Green-light, and holmium laser vaporesection, respectively (p < 0.001). At meta-regression analysis, none of the retrieved covariates was able to significantly influence the cumulative outcomes reported. ER for postoperative complications and early outpatient visit showed a pooled estimate of 18.6% (95% CI: 13.2-23.9) and 7.7% (95% CI: 4.3-11), respectively. Conclusions: Our analysis revealed how transurethral procedures for BPH on an outpatient setting are overall reliable and safe. Of note, there were significant outcome differences between groups with regard to type of surgical procedure, perioperative prostate volume, and discharge protocol suggesting the need for further prospective analysis to better elucidate the best strategy in such outpatient conduct.
Keywords: Green-light; HoLEP; TURP; benign prostatic hyperplasia; laser surgery; outpatient surgery.
Similar articles
-
Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).BJU Int. 2012 Dec;110(11 Pt C):E845-50. doi: 10.1111/j.1464-410X.2012.11290.x. Epub 2012 Jun 15. BJU Int. 2012. PMID: 22702908
-
Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis.World J Urol. 2018 Sep;36(9):1355-1364. doi: 10.1007/s00345-018-2287-6. Epub 2018 Apr 12. World J Urol. 2018. PMID: 29651642
-
A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).J Urol. 2003 Oct;170(4 Pt 1):1270-4. doi: 10.1097/01.ju.0000086948.55973.00. J Urol. 2003. PMID: 14501739 Clinical Trial.
-
The diagnostic value of prostate cancer between holmium laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia: A retrospective comparative study.Int J Surg. 2020 Jul;79:217-221. doi: 10.1016/j.ijsu.2020.05.025. Epub 2020 May 21. Int J Surg. 2020. PMID: 32447004
-
A Systematic Review and Meta-analysis of Efficacy and Safety Following Holmium Laser Enucleation of Prostate and Transurethral Resection of Prostate for Benign Prostatic Hyperplasia.Urology. 2019 Sep;131:14-20. doi: 10.1016/j.urology.2019.03.034. Epub 2019 May 24. Urology. 2019. PMID: 31129190
Cited by
-
Influence of operative time and blood loss on surgical margins and functional outcomes for laparoscopic versus robotic-assisted radical prostatectomy: a prospective analysis.Cent European J Urol. 2021;74(4):503-515. doi: 10.5173/ceju.2021.0177. Epub 2021 Nov 29. Cent European J Urol. 2021. PMID: 35083069 Free PMC article.
-
Same-day trial of void and discharge following standard vs. MOSESTM holmium laser enucleation of the prostate: A single-center experience.Can Urol Assoc J. 2023 Jan;17(1):E23-E28. doi: 10.5489/cuaj.7983. Can Urol Assoc J. 2023. PMID: 36121886 Free PMC article.
-
A warning system for urolithiasis via retrograde intrarenal surgery using machine learning: an experimental study.BMC Urol. 2022 Jun 6;22(1):80. doi: 10.1186/s12894-022-01032-5. BMC Urol. 2022. PMID: 35668401 Free PMC article.
-
A Cost-Benefit Analysis of Bipolar TURP for the Treatment of Bladder Outflow Obstruction.Res Rep Urol. 2021 Jul 9;13:487-494. doi: 10.2147/RRU.S277480. eCollection 2021. Res Rep Urol. 2021. PMID: 34268258 Free PMC article. Review.
-
Ambulatory surgery for Moses™ holmium laser enucleation of the prostate A prospective, real-practice study from a single center.Can Urol Assoc J. 2023 Aug;17(8):E228-E235. doi: 10.5489/cuaj.8229. Can Urol Assoc J. 2023. PMID: 37581561 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical